Waqar Haque,Edward Brian Butler,Bin S. Teh
Abstract:Breast cancer is diagnosed in nearly 3 million people worldwide. Radiation therapy is an integral component of disease management for patients with breast cancer, and is used after breast-conserving surgery or a mastectomy to reduce the risk of a local recurrence. The following review describes the methods used to personalize radiation therapy by optimizing patient selection, using advanced treatment techniques to lessen the radiation dose to normal organs, and using hypofractionation in order to shorten the duration of radiation treatment.
What problem does this paper attempt to address?
The main purpose of this paper is to explore personalized approaches to radiotherapy for breast cancer, aiming to optimize patient selection, reduce radiation doses to normal organs, and shorten treatment times. Specifically, the paper addresses the following key issues:
1. **Optimal Patient Selection**: By reviewing multiple clinical trials (such as NSABP B21, CALGB 9343, PRIME 2, etc.), it identifies which patients are most likely to benefit from postoperative radiotherapy, particularly for early-stage breast cancer patients.
2. **Radiotherapy Techniques**: It introduces various advanced radiotherapy techniques, such as partial-breast radiation, deep inspiration breath hold (DIBH), and proton therapy, which can better protect the heart and other normal tissues.
3. **Fractionation Schemes**: It explores the effectiveness and safety of hypofractionated radiotherapy, finding that this method of shortening the treatment course can reduce patient treatment time and costs without compromising efficacy.
4. **Genomic Personalized Therapy**: It investigates the role of gene expression analysis (such as the 21-gene Oncotype recurrence score, PAM-50, POLAR, etc.) in predicting the risk of local recurrence, thereby helping to select patients most likely to benefit from radiotherapy.
Through these studies, the paper aims to provide more personalized radiotherapy plans for breast cancer patients, improving treatment outcomes and reducing side effects.